BCL-X and the Apoptotic Machinery of Lymphoma Cells

References

• Oltvai Z. N., Korsmeyer S. J. Checkpoints of dueling dimers foil death wishes. Cell 1994; 79: 189–192
   PubMed Web of Science ®Google Scholar
• William G. T., Smith C. A. Molecular regulation of apoptosis: genetic controls on cell death. Cell 1993; 74: 777–779
   PubMed Web of Science ®Google Scholar
• Korsmeyer S. J. Bcl‐2 initiates a new category of oncogenes: regulators of cell death. Blood 1992; 80: 879–886
   PubMed Web of Science ®Google Scholar
• Yang E., Korsmeyer S. J. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 1996; 88: 386–401
   PubMed Web of Science ®Google Scholar
• Oltvai Z. N., Millman C. L., Korsmeyer S. J. Bcl‐2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programed cell death. Cell 1993; 74: 609–619
   PubMed Web of Science ®Google Scholar
• Yang E., Zha J., Jockel J., Boise L. H., Thompson C. B., Korsmeyer S. J. Bad, a heterodimeric partner for bcl‐S and bcl‐2, displaces bax and promotes cell death. Cell 1995; 80: 285–291
   PubMed Web of Science ®Google Scholar
• Kiefer M. C., Brauer M. J., Powers V. C., Wu J. J., Umansky S. R., Tomei L. D., Barr P. J. Modulation of apoptosis by the widely distributed Bcl‐2 homologue Bak. Nature 1995; 374: 736–739
   PubMed Web of Science ®Google Scholar
• Chittenden T., Harrington E. A., O'Connor R., Flemington C., Luttz R. J., Evan G. I., Guild B. C. Induction of apoptosis by the Bcl‐2 homologue Bak. Nature 1995; 374: 733–736
   PubMed Web of Science ®Google Scholar
• Farrow S. N., White J. H. M., Martinou I., Raven T., Pun K. T., Grinham C. J., Martinou J. C., Brown R. Cloning of a bcl‐2 homologue by interaction with adenovirus E1B 19K. Nature 1995; 374: 731–733
   PubMed Web of Science ®Google Scholar
• Kozopas K. M., Yang T., Buchan H. L., Zhou P., Craig R. W. MCL‐1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to Bcl‐2. Proceedings of the National Academy of Sciences of the United States of America 1993; 90: 3516–3520
   PubMed Web of Science ®Google Scholar
• Takayama S., Sato T., Krajewski S., Kochel K., Irie S., Millan J. A., Reed J. C. Cloning and functional analysis of BAG‐1: a novel Bcl‐2 binding protein with anti‐cell death activity. Cell 1995; 80: 279–284
   PubMed Web of Science ®Google Scholar
• Sato T., Hanada M., Bodrug S., Irie S., Iwama N., Boise L. H., Thompson C. B., Golemis E., Fong L., Wang H. G., Reed J. C. Interactions among members of the Bcl‐2 protein family analysed with a yeast two‐hybrid system. Proceedings of the National Academy of Sciences of the United States of America 1994; 91: 9238–9246
   PubMed Web of Science ®Google Scholar
• Boise L. H., Gonzales‐Garcia M., Postema C. E., Ding L., Lindten T., Turka L. A., Man X., Numez G., Thompson C. B. Bcl‐x, a bcl‐2‐related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993; 74: 597–608
   PubMed Web of Science ®Google Scholar
• Krajewski S., Krajewski M., Shabaik A., Wang H. C., Irie S., Fong L., Reed J. C. Immunohistochemical analysis of in vivo patterns of bcl‐x expression. Cancer Research 1994; 54: 5501–5507
   PubMed Web of Science ®Google Scholar
• Motoyama N., Wang F., Roth K. A., Sawa H., Nakayama K. I., Nakayama K., Neghishi I., Senju S., Zhang Q., Fujii S., Loh D. Y. Massive cell death of immature hemopoietic cells and neurons in bcl‐x deficient mice. Science 1995; 267: 1506–1509
   PubMed Web of Science ®Google Scholar
• Minn A. J., Boise L. H., Thompson C. B. Bcl‐x(S) antagonizes the protective effects of Bcl‐x(L). Journal of Biological Chemistry 1996; 271: 6306–6312
   PubMed Web of Science ®Google Scholar
• Cheng E. H., Levine B., Boise L. H., Thompson C. B., Hardwick J. M. Bax‐independent inhibition of apoptosis by Bcl‐XL. Nature 1996; 379: 554–556
   PubMed Web of Science ®Google Scholar
• Muchmore S. W., Sattler M., Liang H., Meadows R. P., Harlan J. E., Yoon H. S., Nettesheim D., Chang B. S., Thompson C. B., Wong S. L., Ng S. L., Fesik S. W. X‐ray and NMR structure of human Bcl‐xL, an inhibitor of programmed cell death. Nature 1996; 381: 335–341
   PubMed Web of Science ®Google Scholar
• Park J. R., Bernstein I. D., Hockenberry D. M. Primitive human hematopoietic precursors express bclx but not bcl2. Blood 1995; 86: 868–876
   PubMed Web of Science ®Google Scholar
• Tuscano J. M., Druey K. M., Riva A., Pena J., Thompson C. B., Kehrl J. H. Bcl‐x rather than Bcl‐2 mediates CD40‐dependent centrocyte survival in the germinal center. Blood 1996; 88: 1359–1364
   PubMed Web of Science ®Google Scholar
• Choi M. S., Holmann M., Atkins C. J., Klaus G. G. Expression of bcl‐x during mouse B‐cell differentiation and following activation by various stimuli. European Journal of Immunology 1996; 26: 676–82
   PubMed Web of Science ®Google Scholar
• Bakhshi A., Jensen J. P., Goldman P., Wright J. J., McBride O. W., Epstein A. L., Korsmeyer S. J. Cloning the chromosomal breakpoint of t(14;18) in human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 1985; 41: 899–906
   PubMed Web of Science ®Google Scholar
• Cleary M. L., Smith S. D., Sklar J. Cloning and structural analysis of cDNAs for bcl‐2 and hybrid bcl‐2 immunoglobulin transcript resulting from the t(14;18) translocation. Cell 1986; 47: 19–28
   PubMed Web of Science ®Google Scholar
• Branet F., Brousset P., Krajewski S., Schlaifer D., Selves J., Reed J. C., Caron P. Expression of the cell death‐inducing gene bax in carcinomas developed from the follicular cells of the thyroid gland. Journal of Clinical Endocrinology and Metabolism 1996; 81: 2726–2730
   PubMed Web of Science ®Google Scholar
• Krajewska M., Moss S. F., Krajewski S., Song K., Holt P. R., Reed J. C. Elevated expression of Bcl‐X and reduced Bak in primary colorectal adenocarcinomas. Cancer Research 1996; 56: 2422–2427
   PubMed Web of Science ®Google Scholar
• Naik P., Karrim J., Hanahan D. The rise and fall of apoptosis during multi‐stage tumorogenesis: down regulation contributes to tumor progresion from angiogenic progenitors. Genes and Development 1996; 10: 2105–2116
   PubMed Web of Science ®Google Scholar
• Michaud G. Y., Kamesaki H., Cossman J. Expression of bclx in T‐cells. leukemia Research 1996; 20: 683–691
   PubMed Web of Science ®Google Scholar
• Gauthier E. R., Piche L., Lemieux G., Lemieux R. Role of bcl‐X(L) in the control of apoptosis in murine myeloma cells. Cancer Research 1996; 56: 1451–1456
   PubMed Web of Science ®Google Scholar
• Han Z., Chatterjee D., Early J., Pantazis P., Hendrickson E. A., Wyche J. H. Isolation and characterization of an apoptosis‐resistant variant of human leukemia HL‐60 cells that has switched expression from Bcl‐2 to Bcl‐xL. Cancer Research 1996; 56: 1621–1628
   PubMed Web of Science ®Google Scholar
• Schlaifer D., Krajewski S., Galoin G., Rigal‐Huguet F., Laurent G., Massip P., Pris J., Delsol G., Reed J. C., Brousset P. Immunodetection of apoptosis‐regulating proteins in lymphomas from patients with and without human deficiency virus infection. American Journal of Pathology 1995; 149: 177–185
   Web of Science ®Google Scholar
• Schlaifer D., March M., Krajewski S., Laurent G., Pris J., Delsol G., Reed J. C., Brousset P. High expression of the Bcl‐x gene in Reed Sternberg cells of Hodgkin's disease. Blood 1995; 85: 2671–2674
   PubMed Web of Science ®Google Scholar
• Xerri L., Pare P., Brousset P., Schlaifer D., Hassoun J., Reed J. C., Krajewski S., Birnbaum D. Predominant expression of the long isoform of BCL‐X (BCL‐XL) in human lymphomas. British Journal of Haematology 1996; 92: 900–906
   PubMed Web of Science ®Google Scholar
• Foreman K. E., Wrone‐Smith T., Boise L. H., Thompson C. G., Polvrerini P. J., Simonian P. L., Nunez G., Nickoloff B. J. Kaposi's sarcoma tumor cells preferentially express Bcl‐xL. American Journal of Pathology 1996; 149: 795–803
   PubMed Web of Science ®Google Scholar
• Krajewski S., Bodrug S., Gascoyne R., Berean K., Krajewska M., Reed J. C. Immunohistochemical analysis of mcl‐1 and bcl‐2 proteins in normal and neoplastic lymph nodes. American Journal of Pathology 1994; 145: 515–525
   PubMed Web of Science ®Google Scholar
• Armitage R. J. Tumor necrosis factor receptor super‐family members and their ligands. Current Biology 1994; 6: 407–413
   Google Scholar
• Itoh N., Yonehara S., Ishii A., Yonehara M., Mizushima S., Sameshima M., Hase A., Seto Y., Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66: 233–243
   PubMed Web of Science ®Google Scholar
• Oehm A., Behrmann I., Falk W., Pawlita M., Maier G., Klas C., Li‐Weber M., Richards S., Dhein J., Trauth B. C., Ponsting H., Krammer P. Purification and molecular cloning of the APO‐1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor super‐family. Journal of Biological Chemistry 1992; 267: 10709–10715
   PubMed Web of Science ®Google Scholar
• Nagata S., Golstein P. The Fas death factor. Science 1995; 267: 1449–1456
   PubMed Web of Science ®Google Scholar
• Schulze‐Osthoff K. The Fas/APO‐1 receptor and its deadly ligand. Trends in Cell Biology 1994; 4: 421–425
   PubMedGoogle Scholar
• Debatin K. M., Goldman C. K., Bamford R., Waldmann T. A., Krammer P. H. Monoclonal antibody‐mediated apoptosis in adult T‐cell leukemia. Lancet 1990; 335: 497–500
   PubMed Web of Science ®Google Scholar
• Debatin K. M., Goldman C. K., Waldmann T. A., Krammer P. H. APO‐1 induced apoptosis of leukemia cells from patients with adult T‐cell leukemia. Blood 1993; 81: 2972–2977
   PubMed Web of Science ®Google Scholar
• Suda T., Nagata S. Purification and characterization of the Fas ligand that induces apoptosis. Journal of Experimental Medicine 1994; 179: 873–878
   PubMed Web of Science ®Google Scholar
• Suda T., Takahashi T., Goldstein P., Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75: 1169–1178
   PubMed Web of Science ®Google Scholar
• Takahashi T., Tanaka M., Inazawa J., Abe T., Suda T., Nagata S. Human FAS ligand: gene structure, chromosomal localization and species specificity. International Immunology 1994; 6: 1567–1574
   PubMed Web of Science ®Google Scholar
• Watanabe‐Fukunaga R., Brannan C. I., Copeland N. G., Jenkins N. A., Nagata S. Lymphoproliferation disorder in mice explained by defects in FAS antigen that mediates apoptosis. Nature 1992; 356: 314–317
   PubMed Web of Science ®Google Scholar
• Takahashi T., Tanaka M., Brannan C. I., Jenkins N. A., Copeland N. G., Suda T., Nagata S. Generalized lymphoproliferative disease in mice, caused by a point mutation in the FAS Ligand. Cell 1994; 76: 969–976
   PubMed Web of Science ®Google Scholar
• Lynch D. H., Watson M. L., Alderson M. R., Baum P. R., Miller R. E., Tough T., Gibson M., Davis‐Smith T., Smith C. A., Hunter K., Bhat D., Din W., Goodwin R. G., Seldin M. F. The mouse FAS‐ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1994; 1: 131–136
   PubMed Web of Science ®Google Scholar
• Ramsdell F., Seaman M. S., Miller E., Tough T. W., Alderson M. R., Lynch D. H. gld/gld mice are unable to express a functional ligand for FAS. European Journal of Immunology 1994; 24: 928–933
   PubMed Web of Science ®Google Scholar
• Fisher G. H., Rosenberg F. J., Straus S. E., Dale J. K., Middelton L. A., Lin A. Y., Strober W., Lenardo M. J., Puck J. M. Dominant interfering FAS gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995; 81: 935–946
   PubMed Web of Science ®Google Scholar
• Rieux‐Laucat F., Le Deist F., Hivroz C., Roberts I. A. G., Debatin K. M., Fischer A., de Villartay J. P. Mutations in FAS associated with human lymphoproliferative syndrome and autoimmunity. Science 1995; 268: 1347–1349
   PubMed Web of Science ®Google Scholar
• Xerri L., Carbuccia N., Pare P., Hassoun J., Birg F. Frequent expression of FAS/APO‐1 in Hodgkin's disease and anaplastic large cell lymphomas. Histopathology 1995; 27: 235–241
   PubMed Web of Science ®Google Scholar
• Xerri L., Carbuccia N., Pare P., Birg F. Search for rearrangements and/or allelic loss of the FAS‐APOI gene in 101 human lymphomas. American Journal of Clinical Pathology 1995; 104: 424–430
   PubMed Web of Science ®Google Scholar
• Möller P., Henne C., Leithäuser F., Eichelman A., Schmidt A., Briiderlein S., Dhein J., Krammer P. H. Coregulation of the APO‐I antigen with intercellular adhesion molecule‐1 (CD54) in tonsillar B‐cells and coordinate expression in follicular center B‐cells and in follicle center and mediastinal B‐cell lymphomas. Blood 1993; 81: 2067–2075
   PubMed Web of Science ®Google Scholar
• Peng S. L., Robert M. A., Hayday A. C., Craft J. A tumor suppressor function for FAS (CD95) revealed in T‐cell deficient mice. Journal of Experimental Medicine 1996; 184: 1149–1154
   PubMed Web of Science ®Google Scholar
• Westendorf J. J., Lammert J. M., Jelinek D. F. Expression and function of FAS (APO‐1/CD95) in patient myeloma cells and myeloma cell lines. Blood 1995; 85: 3566–3576
   PubMed Web of Science ®Google Scholar
• Erhardt P., Cooper G. M. Activation of the CPP32 apoptotic protease by distinct signaling pathways with differential sensitivity to Bcl‐xL. Journal of Biological Chemistry 1996; 271: 17601–17604
   PubMed Web of Science ®Google Scholar
• Martin S. J., Green D. R. Protease activation during apoptosis: death by a thousand cuts?. Cell 1995; 82: 349–352
   PubMed Web of Science ®Google Scholar
• Whyte M. ICE/CED‐3 proteases in apoptosis. Trends in Cell Biology 1996; 6: 245–247
   PubMed Web of Science ®Google Scholar
• Henkart P. A. ICE family proteases: mediators of all apoptotic cell death?. Immunity 1996; 4: 195–201
   PubMed Web of Science ®Google Scholar
• Elis H. M., Horvitz H. R. Genetic control of programmed cell death in the nematod Caenorhabditis elegans. Cell 1986; 44: 817–829
   PubMed Web of Science ®Google Scholar
• Yuan J., Horvitz H. R. Genetic mosaic analysis of ced‐3 and ced‐4, two genes that control programmed cell death in the nematode C. elegans. Developmental Biology 1990; 138: 33–41
   PubMed Web of Science ®Google Scholar
• Yuan J., Shaham S., Ledoux S., Ellis H. M., Horvitz H. R. The C. elegans cell death gene ced‐3 encodes a protein similar to mammalian interleukin‐1β‐converting enzyme. Cell 1993; 75: 641–652
   PubMed Web of Science ®Google Scholar
• Cerretti D. P., Koslosky C. J., Mosley B., Nelson N., Ness K. V., Greenstreet T. A., March C. J., Kronheim S. R., Druck T., Cannizaro L. A., Huebner K., Back R. A. Molecular cloning of the interleukin‐1β‐converting enzyme. Science 1995; 256: 97–100
   Web of Science ®Google Scholar
• Thornberry N. A., Bull H. G., Calaycay J. R., Chapman K. T., Hownard A. D., Kostura M. J., Miller D. K., Molineaux S. M., Weidner J. R., Aunins J., Elliston K. O., Ayala J. M., Casano F. J., Chin J., Ding G. J. F., Egger L. A., Gaffney E. P., Limjuco G., Palyha O. C., Raju S. M., Ralando A. M., Salley J. P., Yamin T. T., Lee T. D., Shivley J. E., MacCross M., Mumford R. A., Schnidt J. A., Tocci M. J. A novel heterodimeric cysteine protease is required for interleukin‐1β processing in monocytes. Nature 1992; 356: 768–774
   PubMed Web of Science ®Google Scholar
• Wang L., Miura M., Bergeron L., Zhu H., Yuan J. Ich‐1, an Ice/ced‐3‐related gene, encodes both positive and negative regulators of programmed cell death. Cell 1994; 78: 739–750
   PubMed Web of Science ®Google Scholar
• Fernandes‐Alnemri T., Litwach G., Alnemri E. S. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced‐3 and mammalian interleukin‐1β‐converting enzyme. Journal of Biological Chemistry 1994; 269: 30761–30764
   PubMed Web of Science ®Google Scholar
• Kamens J., Paskind M., Hugunin M., Talanian R. V., Allen H., Banach D., Bump N., Hackett M., Johnston C. G., Li P., Mankovich J. A., Terranova M., Ghayur T. Identification and characterization of ICH‐2, a novel member of the interleukin‐1 beta‐converting enzyme family of cysteine proteases. Journal of Biological Chemistry 1995; 270: 15250–15256
   PubMed Web of Science ®Google Scholar
• Fernandes‐Alnemri T., Litwack G., Alnemri E. S. Mch2, a new member of the apoptotic Ced‐3/Ice cysteine protease gene family. Cancer Research 1995; 55: 2737–2742
   PubMed Web of Science ®Google Scholar
• Faucheu C., Diu A., Chan A. W., Blanchet A. M., Miossec C., Hervé F., Collard‐Dutilleul V., Gu Y., Aldape R. A., Lippke J. A., Rocher C., Su M. S. S., Livingston D. J., Hercend T., Lalanne J. L. A novel human protease similar to the interleukin‐1 beta converting enzyme induces apoptosis in transfected cells. EMBO Journal 1995; 14: 1914–1922
   PubMed Web of Science ®Google Scholar
• Miura M., Zhu H., Rotello R., Hartwieg E. A., Yuan J. Induction of apoptosis in fibroblasts by IL‐1β‐converting enzyme, a mammalian homolog of the C. elegans cell death gene ced‐3. Cell 1993; 75: 653–660
   PubMed Web of Science ®Google Scholar
• Kaufmann S. H., Desnoyers S., Ottaviano Y., Davidson N. E., Poirier G. G. Specific proteolytic cleavage of poly(ADP‐ribose) polymerase: an early marker of chemotherapy‐induced apoptosis. Cancer Research 1993; 53: 3976–3985
   PubMed Web of Science ®Google Scholar
• Lazebnik Y. A., Kaufmann S. H., Desnoyers S., Poirier G. G., Earnshaw W. C. Cleavage of poly(ADP‐ribose) polymerase by a proteinase with properties like ICE. Nature 1994; 371: 346–347
   PubMed Web of Science ®Google Scholar
• Tewari M., Quan L. T., O'Rourke K., Desnoyers S., Zeng Z., Beidler D. R., Poirier G. G., Salvesen G. S., Dixit V. M. Yama/CPP32b, a mammalian homolog of CED‐3, is a CrmA‐inhibitable protease that cleaves the death substrate poly(ADP‐ribose) polymerase. Cell 1995; 81: 801–809
   PubMed Web of Science ®Google Scholar
• Gu Y., Sarnecki C., Aldape R. A., Livingston D. J., Su M. S. Cleavage of poly(ADP‐ribose) polymerase by interleukin‐1 beta converting enzyme and its homologs TX and Nedd‐2. Journal of Biological Chemistry 1995; 270: 18715–18718
   PubMed Web of Science ®Google Scholar
• Nicholson D. W., Ali A., Thornberry N. A., Vaillancourt J. P., Ding C. K., Gallant M., Gareau Y., Griffin P. R., Labelle M., Lazebnik Y. A., Munday N. A., Raju S. M., Smulson M. E., Yamin T. T., Yu V. L., Miller D. K. Identification and inhibition of the ICE/CED‐3 protease necessary for mammalian apoptosis. Nature 1195; 376: 37–43
   Google Scholar
• Enari M., Talanian R. V., Wong W. W., Nagata S. Sequential activation of ICE‐like and CPP32‐like proteases during FAS‐mediated apoptosis. Nature 1996; 380: 723–726
   PubMed Web of Science ®Google Scholar
• Casciola‐Rosen L., Nicholson D. W., Cong T., Rowan K. R., Thornberry N. A., Miller D. K., Rosen A. Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. Journal of Experimental Medicine 1996; 183: 1957–1964
   PubMed Web of Science ®Google Scholar
• Xerri L., Devilard E., Ayello C., Brousset P., Reed J. C., Emile J. F., Hassoun J., Parmentier S., Birg F. Cysteine protease CPP32, but not Ichl‐L. Is expressed in germinal center B‐cells and their neoplastic counterparts. Human Pathology 1997, In press
   PubMed Web of Science ®Google Scholar
• Sumantran V. N., Ealovega M. W., Nunez G., Clarke M. F., Wicha M. S. Overexpression of bclx‐S sensitizes MCF7 cells to chemotherapy‐induced apoptosis. Cancer Research 1995; 55: 2507–2510
   PubMed Web of Science ®Google Scholar
• Minn A. J., Rudin C. M., Boise L. W., Thompson C. B. Expression of bcl‐xL can confer a multidrug resistance phenotype. Blood 1995; 86: 1903–1910
   PubMed Web of Science ®Google Scholar
• Ealovega M. W., McGinnis P. K., Sumantran V. N., Clarke M. F., Wicha M. S. Bcl‐xS gene therapy induces apoptosis of human mammary tumors in nude mice. Cancer Research 1996; 56: 1965–1969
   PubMed Web of Science ®Google Scholar
• Clarke M. F., Apel I. J., Benedict M. A., Eipers P. G., Sumantran V., Gonzalez‐Garcia M., Doedens M., Fukanaga M., Davidson B., Dick J. E., Minn A. J., Boise L. H., Thompson C. G., Wicha M., Nunez G. A recombinant bcl‐xS adenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells. Proceedings of the National Academy of Sciences of the United States of America 1995; 92: 11024–11028
   PubMed Web of Science ®Google Scholar